| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Tankyrase-bd_C | 4.81e-05 | 2 | 130 | 2 | IPR032764 | |
| Domain | Aquaporin_12 | 4.81e-05 | 2 | 130 | 2 | IPR023265 | |
| Domain | Tankyrase_bdg_C | 4.81e-05 | 2 | 130 | 2 | SM01319 | |
| Domain | Tankyrase_bdg_C | 4.81e-05 | 2 | 130 | 2 | PF15327 | |
| Domain | BAT2_N | 1.44e-04 | 3 | 130 | 2 | PF07001 | |
| Domain | DUF4592 | 1.44e-04 | 3 | 130 | 2 | IPR028030 | |
| Domain | DUF4592 | 1.44e-04 | 3 | 130 | 2 | PF15262 | |
| Domain | BAT2_N | 1.44e-04 | 3 | 130 | 2 | IPR009738 | |
| Domain | Aquaporin_11/12 | 1.44e-04 | 3 | 130 | 2 | IPR016697 | |
| Domain | PRRC2 | 1.44e-04 | 3 | 130 | 2 | IPR033184 | |
| Domain | S_TKc | CDC42BPG SPEG PAK4 BRSK2 PRAG1 STK10 MAPK15 MAST4 EIF2AK4 WNK2 | 2.10e-04 | 359 | 130 | 10 | SM00220 |
| Domain | Arrestin_N | 2.86e-04 | 4 | 130 | 2 | IPR014753 | |
| Domain | Arrestin_CS | 2.86e-04 | 4 | 130 | 2 | IPR017864 | |
| Domain | ARRESTINS | 2.86e-04 | 4 | 130 | 2 | PS00295 | |
| Domain | Arrestin | 2.86e-04 | 4 | 130 | 2 | IPR000698 | |
| Domain | - | 2.86e-04 | 4 | 130 | 2 | 2.60.40.840 | |
| Domain | Pkinase | CDC42BPG SPEG PAK4 BRSK2 PRAG1 STK10 MAPK15 MAST4 EIF2AK4 WNK2 | 3.37e-04 | 381 | 130 | 10 | PF00069 |
| Domain | Kinase-like_dom | CDC42BPG ERBB2 SPEG PAK4 BRSK2 PRAG1 STK10 MAPK15 MAST4 ALPK3 EIF2AK4 WNK2 | 4.07e-04 | 542 | 130 | 12 | IPR011009 |
| Domain | Prot_kinase_dom | CDC42BPG ERBB2 SPEG PAK4 BRSK2 PRAG1 STK10 MAPK15 MAST4 EIF2AK4 WNK2 | 6.26e-04 | 489 | 130 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDC42BPG ERBB2 SPEG PAK4 BRSK2 PRAG1 STK10 MAPK15 MAST4 EIF2AK4 WNK2 | 6.69e-04 | 493 | 130 | 11 | PS50011 |
| Domain | DUF3669_Znf | 7.08e-04 | 6 | 130 | 2 | IPR022137 | |
| Domain | DUF3669 | 7.08e-04 | 6 | 130 | 2 | PF12417 | |
| Domain | Ser/Thr_kinase_AS | 8.92e-04 | 357 | 130 | 9 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 9.83e-04 | 362 | 130 | 9 | PS00108 | |
| Domain | - | 9.87e-04 | 7 | 130 | 2 | 2.60.40.640 | |
| Domain | Arrestin_C | 1.31e-03 | 8 | 130 | 2 | IPR014752 | |
| Domain | PROTEIN_KINASE_ATP | CDC42BPG ERBB2 SPEG PAK4 BRSK2 STK10 MAPK15 MAST4 EIF2AK4 WNK2 | 1.41e-03 | 459 | 130 | 10 | PS00107 |
| Domain | Arrestin-like_N | 2.09e-03 | 10 | 130 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 2.09e-03 | 10 | 130 | 2 | IPR011022 | |
| Domain | Arrestin_C | 2.09e-03 | 10 | 130 | 2 | SM01017 | |
| Domain | Arrestin_C | 2.09e-03 | 10 | 130 | 2 | PF02752 | |
| Domain | Arrestin_N | 2.09e-03 | 10 | 130 | 2 | PF00339 | |
| Domain | ZF_CXXC | 2.54e-03 | 11 | 130 | 2 | PS51058 | |
| Domain | Znf_CXXC | 2.54e-03 | 11 | 130 | 2 | IPR002857 | |
| Domain | zf-CXXC | 2.54e-03 | 11 | 130 | 2 | PF02008 | |
| Domain | PDZ | 3.07e-03 | 141 | 130 | 5 | PF00595 | |
| Domain | FA | 3.57e-03 | 13 | 130 | 2 | PF08736 | |
| Domain | FERM-adjacent | 3.57e-03 | 13 | 130 | 2 | IPR014847 | |
| Domain | FA | 3.57e-03 | 13 | 130 | 2 | SM01195 | |
| Domain | PDZ | 3.78e-03 | 148 | 130 | 5 | SM00228 | |
| Domain | - | 4.00e-03 | 150 | 130 | 5 | 2.30.42.10 | |
| Domain | PDZ | 4.12e-03 | 151 | 130 | 5 | PS50106 | |
| Domain | MIP | 4.14e-03 | 14 | 130 | 2 | PF00230 | |
| Domain | MIP | 4.14e-03 | 14 | 130 | 2 | PS00221 | |
| Domain | PDZ | 4.24e-03 | 152 | 130 | 5 | IPR001478 | |
| Domain | - | 4.76e-03 | 15 | 130 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 4.76e-03 | 15 | 130 | 2 | IPR023271 | |
| Domain | MIP | 4.76e-03 | 15 | 130 | 2 | IPR000425 | |
| Domain | Protein_kinase_ATP_BS | 5.07e-03 | 379 | 130 | 8 | IPR017441 | |
| Domain | PBD | 6.11e-03 | 17 | 130 | 2 | PF00786 | |
| Domain | - | 6.84e-03 | 18 | 130 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 6.84e-03 | 18 | 130 | 2 | SM00014 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPRY2 ERBB2 ARSJ KMT2B PCNX3 SZT2 SPEG SIPA1L3 SMG5 FBXL19 BCL9 STK11IP PRAG1 BAHD1 RNF43 CIC STK10 DACT1 SGSM2 CASKIN1 TTLL4 CACNA1H TNKS1BP1 SPEN WNK2 | 1.78e-12 | 1105 | 138 | 25 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 ERBB2 SIPA1L3 PAK4 BRSK2 ZNF629 EPB41L3 PRAG1 DENND2B CIC FAM83B KIAA1671 MAST4 CEP112 PRRC2C SYNE2 TJP2 TNKS1BP1 MTCL1 TP53BP2 | 2.35e-10 | 861 | 138 | 20 | 36931259 |
| Pubmed | ERBB2 SZT2 JADE2 PAK4 SMG5 NACAD BAHD1 MAST4 ZC3H4 CASKIN1 TTLL4 TNKS1BP1 EIF2AK4 WNK2 | 2.82e-08 | 529 | 138 | 14 | 14621295 | |
| Pubmed | KMT2B SCARF2 PCDHA2 EPB41L3 TULP1 CHRD RPUSD2 SPEN WNK2 TP53BP2 SOS2 | 9.09e-08 | 329 | 138 | 11 | 17474147 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | SPRY2 ERBB2 PCNX3 LEMD3 SCARF2 PAK4 EPB41L3 SLC6A6 STK10 RFTN1 FARP1 | 3.54e-07 | 377 | 138 | 11 | 38117590 |
| Pubmed | MAPK8IP1 PRR36 SIPA1L3 BCL9 EPB41L3 RPH3A FRY ZC3H4 PRRC2C FARP1 CASKIN1 SYNE2 MTCL1 PRRC2A WNK2 TP53BP2 | 1.51e-06 | 963 | 138 | 16 | 28671696 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 3.85e-06 | 59 | 138 | 5 | 28813667 | |
| Pubmed | 3.86e-06 | 104 | 138 | 6 | 9205841 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.11e-06 | 430 | 138 | 10 | 35044719 | |
| Pubmed | MAPK8IP1 SPRY2 CHAF1B ERCC1 JADE2 SIPA1L3 SMG5 DSCAML1 RPH3A NFE2L3 FRY NSMF SGSM2 RNF216 UROD PRRC2A SOS2 | 1.43e-05 | 1285 | 138 | 17 | 35914814 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20056609 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 35933456 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 36167651 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22242112 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27452469 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 1.56e-05 | 2 | 138 | 2 | 15809071 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29948376 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19726746 | ||
| Pubmed | PABIR1 LEMD3 TPRN SIPA1L3 PAK4 CIC PCF11 KIAA1671 RFTN1 FARP1 SYNE2 PHLPP1 EIF2AK4 PRRC2A TP53BP2 | 1.94e-05 | 1049 | 138 | 15 | 27880917 | |
| Pubmed | 2.60e-05 | 87 | 138 | 5 | 12465718 | ||
| Pubmed | ERBB2 ERCC1 ARL16 PCNX3 TACC2 SEMA3G BCL9 CCDC51 TULP1 DACT1 HMGA2 NSMF YIPF1 ZC3H4 EIF2AK4 ARHGAP45 | 2.74e-05 | 1215 | 138 | 16 | 15146197 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | REXO4 PAK4 ZNF629 SMG5 EPB41L3 ZC3H4 PRRC2C FARP1 TJP2 SMG9 SPEN PRRC2A | 3.38e-05 | 724 | 138 | 12 | 36232890 |
| Pubmed | 3.41e-05 | 225 | 138 | 7 | 12168954 | ||
| Pubmed | TACC2 EPB41L3 STK10 ZC3H4 TJP2 TNKS1BP1 MTCL1 SPEN PRRC2A CTU1 | 3.48e-05 | 503 | 138 | 10 | 16964243 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.04e-05 | 231 | 138 | 7 | 16452087 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 21321940 | ||
| Pubmed | β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. | 4.68e-05 | 3 | 138 | 2 | 32404425 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28124401 | ||
| Pubmed | Identification of receptor binding-induced conformational changes in non-visual arrestins. | 4.68e-05 | 3 | 138 | 2 | 24867953 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 16809338 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 28062183 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 27741011 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 23140436 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 9852134 | ||
| Pubmed | Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1. | 4.68e-05 | 3 | 138 | 2 | 29540470 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 5.59e-05 | 102 | 138 | 5 | 15778465 | |
| Pubmed | 5.59e-05 | 102 | 138 | 5 | 10231032 | ||
| Pubmed | 5.65e-05 | 19 | 138 | 3 | 24564958 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CHAF1B KMT2B BCL9 CIC PCF11 STK10 ZC3H4 TJP2 TNKS1BP1 COASY SPEN PRRC2A | 6.41e-05 | 774 | 138 | 12 | 15302935 |
| Pubmed | SIPA1L3 PAK4 EPB41L3 FAM83B KIAA1671 TBC1D22A TJP2 MTCL1 TP53BP2 | 7.72e-05 | 446 | 138 | 9 | 24255178 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPG ERBB2 JADE2 SIPA1L3 BLNK DENND2B KIAA1671 STK10 ARRB2 TBC1D22A FARP1 SGSM2 CACNA1H EIF2AK4 WNK2 PDZD2 SOS2 | 8.94e-05 | 1489 | 138 | 17 | 28611215 |
| Pubmed | 9.11e-05 | 263 | 138 | 7 | 20932939 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 25589675 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 10704825 | ||
| Pubmed | Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. | 9.33e-05 | 4 | 138 | 2 | 18802075 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 28733084 | ||
| Pubmed | S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. | 9.33e-05 | 4 | 138 | 2 | 18691971 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 11729201 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 23139825 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 10891441 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TPRN ZNF629 TACC2 SOX13 CIC FAM83B KIAA1671 PRRC2C TNKS1BP1 SPEN | 1.26e-04 | 588 | 138 | 10 | 38580884 |
| Pubmed | The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. | 1.55e-04 | 5 | 138 | 2 | 22174878 | |
| Pubmed | Dopamine receptor D4 internalization requires a beta-arrestin and a visual arrestin. | 1.55e-04 | 5 | 138 | 2 | 26169958 | |
| Pubmed | Spinophilin Is Indispensable for the α2B Adrenergic Receptor-Elicited Hypertensive Response. | 1.55e-04 | 5 | 138 | 2 | 26244553 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 22581458 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 18325490 | ||
| Pubmed | SIPA1L3 BRSK2 ZNF629 EPB41L3 PCF11 SHROOM4 RFTN1 KRBA1 PTCD1 | 1.64e-04 | 493 | 138 | 9 | 15368895 | |
| Pubmed | ATXN7L2 KMT2B EPB41L3 CIC NSMF CHRD SPEN PRRC2A WNK2 TP53BP2 | 1.66e-04 | 608 | 138 | 10 | 16713569 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CDC42BPG SPRY2 REXO4 KMT2B ESX1 DSCAML1 KIAA1671 SLC6A6 FRY CHRD MTCL1 | 1.79e-04 | 736 | 138 | 11 | 29676528 |
| Pubmed | MAPK8IP1 PRR36 SIPA1L3 BRSK2 EPB41L3 RPH3A CRACD PRRC2C FARP1 CRACDL CASKIN1 TJP2 TNKS1BP1 PRRC2A WNK2 TP53BP2 | 1.85e-04 | 1431 | 138 | 16 | 37142655 | |
| Pubmed | 1.95e-04 | 209 | 138 | 6 | 36779422 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 2.32e-04 | 6 | 138 | 2 | 17513486 | |
| Pubmed | 2.32e-04 | 6 | 138 | 2 | 21378163 | ||
| Pubmed | 2.32e-04 | 407 | 138 | 8 | 12693553 | ||
| Pubmed | REXO4 ARL16 LEMD3 SCARF2 EPB41L3 FAM83B PCF11 KIAA1671 ZC3H4 TJP2 SPEN | 2.85e-04 | 777 | 138 | 11 | 35844135 | |
| Pubmed | REXO4 KMT2B PCNX3 LEMD3 SIPA1L3 CIC FAM83B PCF11 KIAA1671 CRACD RFTN1 PTCD1 FARP1 CRACDL SPEN PRRC2A | 3.06e-04 | 1497 | 138 | 16 | 31527615 | |
| Pubmed | Genetic mapping of the beta-arrestin 1 and 2 genes on mouse chromosomes 7 and 11 respectively. | 3.24e-04 | 7 | 138 | 2 | 7613043 | |
| Pubmed | 3.24e-04 | 7 | 138 | 2 | 15173068 | ||
| Pubmed | Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. | 3.24e-04 | 7 | 138 | 2 | 27356767 | |
| Pubmed | Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. | 3.24e-04 | 7 | 138 | 2 | 15218143 | |
| Pubmed | Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma. | 3.24e-04 | 7 | 138 | 2 | 15953601 | |
| Pubmed | 3.24e-04 | 7 | 138 | 2 | 17148612 | ||
| Pubmed | SPRY2 REXO4 PAK4 KCNK4 YIPF1 FBXO31 FARP1 TJP2 RNF216 RNF39 HCRTR2 | 3.42e-04 | 794 | 138 | 11 | 11076863 | |
| Pubmed | 3.78e-04 | 332 | 138 | 7 | 37433992 | ||
| Pubmed | Bridging expressed sequence alignments through targeted cDNA sequencing. | 4.31e-04 | 8 | 138 | 2 | 15028280 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ERBB2 SIPA1L3 PAK4 EPB41L3 FAM83B KIAA1671 TJP2 TNKS1BP1 TP53BP2 | 4.44e-04 | 565 | 138 | 9 | 25468996 |
| Pubmed | 4.45e-04 | 689 | 138 | 10 | 36543142 | ||
| Pubmed | 5.53e-04 | 9 | 138 | 2 | 34873237 | ||
| Pubmed | Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages. | 5.53e-04 | 9 | 138 | 2 | 18180038 | |
| Pubmed | REXO4 ATXN7L2 KMT2B ZNF629 SMG5 BCL9 SOX13 CIC PCF11 KIAA1671 HOXD11 PRRC2C SYNE2 SPEN PRRC2A | 5.73e-04 | 1429 | 138 | 15 | 35140242 | |
| Pubmed | 5.94e-04 | 469 | 138 | 8 | 27634302 | ||
| Pubmed | 6.13e-04 | 591 | 138 | 9 | 15231748 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.21e-04 | 361 | 138 | 7 | 26167880 | |
| Pubmed | 6.27e-04 | 42 | 138 | 3 | 23444366 | ||
| Pubmed | 6.89e-04 | 10 | 138 | 2 | 31234534 | ||
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 6.89e-04 | 10 | 138 | 2 | 12958361 | |
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 6.89e-04 | 10 | 138 | 2 | 29276034 | |
| Pubmed | Regulation of arrestin-3 phosphorylation by casein kinase II. | 6.89e-04 | 10 | 138 | 2 | 11877451 | |
| Pubmed | 6.89e-04 | 10 | 138 | 2 | 10744724 | ||
| Pubmed | 7.19e-04 | 101 | 138 | 4 | 26949739 | ||
| Pubmed | 8.40e-04 | 11 | 138 | 2 | 27748374 | ||
| Pubmed | Endocardial Hippo signaling regulates myocardial growth and cardiogenesis. | 8.40e-04 | 11 | 138 | 2 | 29727635 | |
| Pubmed | Cloning of the genes encoding two murine and human cochlear unconventional type I myosins. | 8.40e-04 | 11 | 138 | 2 | 9119401 | |
| Pubmed | 8.53e-04 | 750 | 138 | 10 | 11230166 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 8.64e-04 | 497 | 138 | 8 | 36774506 | |
| Pubmed | 1.01e-03 | 12 | 138 | 2 | 17452450 | ||
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 1.05e-03 | 50 | 138 | 3 | 29560723 | |
| Pubmed | COL4A4 PRR36 PAK4 EPB41L3 KIAA1671 HMGA2 FARP1 RPS19BP1 TJP2 PRRC2A SOS2 | 1.10e-03 | 916 | 138 | 11 | 32203420 | |
| Pubmed | 1.18e-03 | 13 | 138 | 2 | 21177258 | ||
| Pubmed | 1.18e-03 | 13 | 138 | 2 | 23307470 | ||
| Interaction | YWHAH interactions | PABIR1 CDC42BPG SPEG SIPA1L3 PAK4 ZNF629 EPB41L3 PRAG1 DENND2B RPH3A CIC FAM83B KIAA1671 ARRB2 MAST4 CEP112 PRRC2C SYNE2 TJP2 TNKS1BP1 MTCL1 WNK2 TP53BP2 | 1.26e-06 | 1102 | 136 | 23 | int:YWHAH |
| Interaction | TOP3B interactions | SPRY2 ERBB2 ARSJ KMT2B PCNX3 SZT2 SPEG SIPA1L3 SMG5 FBXL19 BCL9 STK11IP PRAG1 BAHD1 RNF43 CIC STK10 DACT1 SGSM2 CASKIN1 TTLL4 CACNA1H TNKS1BP1 SPEN PRRC2A WNK2 | 5.01e-06 | 1470 | 136 | 26 | int:TOP3B |
| Interaction | TPX2 interactions | 1.03e-05 | 204 | 136 | 9 | int:TPX2 | |
| Interaction | YWHAE interactions | PABIR1 CHAF1B SIPA1L3 PAK4 BRSK2 ZNF629 TACC2 EPB41L3 PRAG1 DENND2B RNF43 CIC FAM83B KIAA1671 CRACD ARRB2 MAST4 CEP112 TJP2 ARHGAP45 PRRC2A WNK2 TP53BP2 | 1.10e-05 | 1256 | 136 | 23 | int:YWHAE |
| Interaction | YWHAB interactions | PABIR1 CHAF1B SPEG SIPA1L3 PAK4 ZNF629 EPB41L3 DENND2B RNF43 CIC FAM83B KIAA1671 DACT1 ARRB2 MAST4 TBC1D22A CEP112 TJP2 MTCL1 TP53BP2 | 1.54e-05 | 1014 | 136 | 20 | int:YWHAB |
| Interaction | TNRC6A interactions | ARL16 KMT2B TRIM71 SMG5 RNF43 PCF11 TJP2 TNKS1BP1 EIF2AK4 PRRC2A | 2.08e-05 | 280 | 136 | 10 | int:TNRC6A |
| Interaction | YWHAZ interactions | PABIR1 CDC42BPG ERBB2 CHAF1B SPEG SIPA1L3 PAK4 ZNF629 TACC2 EPB41L3 DENND2B CIC FAM83B KIAA1671 CRACD MAST4 CSF2RB CEP112 SYNE2 TJP2 PRRC2A WNK2 TP53BP2 | 2.41e-05 | 1319 | 136 | 23 | int:YWHAZ |
| Interaction | OCLN interactions | ERBB2 PCNX3 SIPA1L3 PAK4 KLRG2 EPB41L3 RNF43 FAM83B KIAA1671 FARP1 TJP2 TNKS1BP1 TP53BP2 | 3.48e-05 | 500 | 136 | 13 | int:OCLN |
| GeneFamily | Classical arrestins | 1.21e-04 | 4 | 82 | 2 | 1312 | |
| GeneFamily | PDZ domain containing | 6.37e-04 | 152 | 82 | 5 | 1220 | |
| GeneFamily | Zinc fingers CXXC-type | 1.30e-03 | 12 | 82 | 2 | 136 | |
| GeneFamily | Aquaporins | 1.78e-03 | 14 | 82 | 2 | 305 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL4A4 SIPA1L3 TRIM71 EPB41L3 RNF43 FARP1 SYNE2 TNKS1BP1 GALNT5 | 7.37e-09 | 187 | 138 | 9 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-08 | 198 | 138 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-08 | 198 | 138 | 9 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-08 | 199 | 138 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.32e-08 | 200 | 138 | 9 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-07 | 186 | 138 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.99e-07 | 198 | 138 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 138 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 138 | 8 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.52e-07 | 162 | 138 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-06 | 179 | 138 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 184 | 138 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-06 | 186 | 138 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 187 | 138 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 191 | 138 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 191 | 138 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.59e-06 | 195 | 138 | 7 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.77e-06 | 197 | 138 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.96e-06 | 199 | 138 | 7 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.64e-06 | 157 | 138 | 6 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.64e-06 | 157 | 138 | 6 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.64e-06 | 157 | 138 | 6 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-05 | 167 | 138 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 170 | 138 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.97e-05 | 178 | 138 | 6 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 179 | 138 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 181 | 138 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 183 | 138 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 183 | 138 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 184 | 138 | 6 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-05 | 185 | 138 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 185 | 138 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 186 | 138 | 6 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 186 | 138 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 186 | 138 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 186 | 138 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.59e-05 | 187 | 138 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-05 | 188 | 138 | 6 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.67e-05 | 188 | 138 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 188 | 138 | 6 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 189 | 138 | 6 | feedac2751ed770f80bc56fec31662b5b3826f58 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 189 | 138 | 6 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-05 | 189 | 138 | 6 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 191 | 138 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.92e-05 | 191 | 138 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 3.01e-05 | 192 | 138 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 192 | 138 | 6 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 192 | 138 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 3.19e-05 | 194 | 138 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.28e-05 | 195 | 138 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 195 | 138 | 6 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.47e-05 | 197 | 138 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 3.47e-05 | 197 | 138 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 198 | 138 | 6 | 50852713c017217c79777c95857097103bcf2fbe | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 198 | 138 | 6 | 9f972f217d2c39d4c0f7d0d4227d0fffe8535b9d | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.67e-05 | 199 | 138 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-05 | 128 | 138 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.71e-05 | 132 | 138 | 5 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.05e-05 | 138 | 138 | 5 | 35880e23ef317862891b54ac6a2265ca03b1d12a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 143 | 138 | 5 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 143 | 138 | 5 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.51e-05 | 147 | 138 | 5 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 149 | 138 | 5 | a6e192bf9bcf3b219e618c465bc451f7c86f49f1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.01e-04 | 149 | 138 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 161 | 138 | 5 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 162 | 138 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 164 | 138 | 5 | d9531848105d606adedde65426177cf851140e31 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 164 | 138 | 5 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 164 | 138 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 166 | 138 | 5 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 166 | 138 | 5 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-04 | 167 | 138 | 5 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.73e-04 | 167 | 138 | 5 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.76e-04 | 90 | 138 | 4 | 7312773889ee8a133d7ea97c4bb7a503b2f67b69 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.83e-04 | 169 | 138 | 5 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.83e-04 | 169 | 138 | 5 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 171 | 138 | 5 | effcc4b6d26eafc2ca6fa08b6fee2689eff48f0f | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 172 | 138 | 5 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.04e-04 | 173 | 138 | 5 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-04 | 174 | 138 | 5 | d67fc8e30cc67fff8f7fdeaccb409d12ca0992c1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-04 | 175 | 138 | 5 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.15e-04 | 175 | 138 | 5 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-04 | 175 | 138 | 5 | 22fd7d9b4d403cc8061316855f78bad0eb705ce9 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 176 | 138 | 5 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 176 | 138 | 5 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 176 | 138 | 5 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 176 | 138 | 5 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 96 | 138 | 4 | 7e02df1f28fea1d962f9b1d3835212765a6642cc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-04 | 177 | 138 | 5 | 3743a7d69db9ac4cad70eb531f7075849f34f16b | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 178 | 138 | 5 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | BORCS6 SIPA1L3 BCL9 SOX13 CIC SLC6A6 RFTN1 TBC1D22A PHLPP1 SOS2 | 3.47e-07 | 198 | 137 | 10 | 3292_DN |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 3.26e-06 | 198 | 137 | 9 | 7189_DN | |
| Disease | 12q14 microdeletion syndrome | 2.02e-05 | 2 | 133 | 2 | C4305140 | |
| Disease | hippocampal volume | 6.33e-05 | 297 | 133 | 8 | EFO_0005035 | |
| Disease | Malignant neoplasm of breast | ERBB2 XIRP1 SCARF2 TACC2 EPB41L3 CIC HOXD11 FARP1 SYNE2 GALNT5 SPEN PRRC2A NOS3 CTU1 TP53BP2 | 1.04e-04 | 1074 | 133 | 15 | C0006142 |
| Disease | non-obstructive coronary artery disease | 1.20e-04 | 4 | 133 | 2 | EFO_1001483 | |
| Disease | Benign Neoplasm | 2.57e-04 | 68 | 133 | 4 | C0086692 | |
| Disease | Neoplasms | 2.57e-04 | 68 | 133 | 4 | C0027651 | |
| Disease | Malignant Neoplasms | 2.93e-04 | 128 | 133 | 5 | C0006826 | |
| Disease | cortical surface area measurement | SPRY2 PCNX3 BRSK2 TRIM71 DACT1 HMGA2 MAST4 TBC1D22A CEP112 PRRC2C RP1L1 MTCL1 PRRC2A WNK2 PDZD2 SOS2 | 3.75e-04 | 1345 | 133 | 16 | EFO_0010736 |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 6.04e-04 | 228 | 133 | 6 | EFO_0003948, MONDO_0004975 | |
| Disease | high grade glioma (is_marker_for) | 9.04e-04 | 42 | 133 | 3 | DOID:3070 (is_marker_for) | |
| Disease | S-warfarin measurement | 9.89e-04 | 97 | 133 | 4 | EFO_0803323 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.29e-03 | 12 | 133 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | brain volume measurement | 1.55e-03 | 595 | 133 | 9 | EFO_0006930 | |
| Disease | cortical thickness | KMT2B TACC2 DACT1 HMGA2 MAST4 TBC1D22A CEP112 GLI4 MTCL1 CTU1 WNK2 PDZD2 SOS2 | 1.60e-03 | 1113 | 133 | 13 | EFO_0004840 |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 1.88e-03 | 54 | 133 | 3 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | lateral ventricle volume change measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0021502 | |
| Disease | ovarian cancer (is_implicated_in) | 2.08e-03 | 56 | 133 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | chronic lymphocytic leukemia | 2.10e-03 | 119 | 133 | 4 | EFO_0000095 | |
| Disease | Pre-Eclampsia | 2.32e-03 | 16 | 133 | 2 | C0032914 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 2.32e-03 | 16 | 133 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | caudal middle frontal gyrus volume measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0010290 | |
| Disease | eosinophil count | CHAF1B ZFAT INPP5D SIPA1L3 PLPPR1 NACAD RPH3A TULP1 CSF2RB CACNA1H TNKS1BP1 NKX3-1 RNF39 ARHGAP45 ZNF282 | 2.95e-03 | 1488 | 133 | 15 | EFO_0004842 |
| Disease | ovarian neoplasm | 3.22e-03 | 134 | 133 | 4 | C0919267 | |
| Disease | hippocampal tail volume | 3.28e-03 | 19 | 133 | 2 | EFO_0009398 | |
| Disease | essential tremor | 3.40e-03 | 136 | 133 | 4 | EFO_0003108 | |
| Disease | Malignant neoplasm of ovary | 3.49e-03 | 137 | 133 | 4 | C1140680 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 3.63e-03 | 20 | 133 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 3.80e-03 | 328 | 133 | 6 | EFO_0008377, EFO_0008378 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 4.00e-03 | 21 | 133 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | portal hypertension (biomarker_via_orthology) | 4.39e-03 | 22 | 133 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Nasopharyngeal carcinoma | 4.39e-03 | 22 | 133 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DPPERGAPPSTFKGT | 1226 | P04626 | |
| GPQTAEGPQPPERKR | 126 | Q8N693 | |
| PRGKPAPASGDTQTP | 261 | Q8IXF9 | |
| GTPPPDSGPLAKDDR | 666 | Q9P2K8 | |
| SPFQCPKEERPGGVP | 1036 | Q96L96 | |
| TPGDAQGSPPELKRP | 531 | Q13112 | |
| PNPARAKGSSPEGLP | 106 | Q8N8E3 | |
| EAGIPGRPDSAPGKP | 421 | P53420 | |
| GKGDLGEPPPTRPTV | 51 | Q0P5N6 | |
| PRGKPAPASGDTQTP | 261 | A6NM10 | |
| PPEREGSGSTKPGTP | 351 | P78524 | |
| PPEITGQVSLPPGKR | 891 | Q13625 | |
| PEKPGPQPSAETTRH | 176 | P32121 | |
| RKVQFAPPEAGPGPS | 166 | P36575 | |
| SEAPRDPPGQAKPRG | 16 | Q86WX3 | |
| EGSPPEKEPSGTRLP | 211 | Q5T6C5 | |
| PPPDTKPGQTESRGR | 556 | Q6PCT2 | |
| PEPSSGPRGEVPLAK | 221 | Q14699 | |
| GPRGEVPLAKQPSSP | 226 | Q14699 | |
| RLQGPPTPAGKETEG | 231 | P78411 | |
| APAEPLSRAGKPPGA | 136 | Q9Y4B5 | |
| LSRAGKPPGAEPPSA | 141 | Q9Y4B5 | |
| PANGRPGARDKSPAP | 1451 | Q6DT37 | |
| PPTEGARAPGKPTLV | 726 | Q9Y5H9 | |
| RPAGPELQTPPGKDG | 201 | Q9Y2U8 | |
| VPGKGPSFPEPLREE | 101 | P06132 | |
| GSPEVKRAHGTPPPV | 1256 | Q8WXD9 | |
| PLPPAPGVKASRGDE | 26 | Q9NSA2 | |
| PTSGVAPDGIPERPK | 986 | A5PL33 | |
| AGSPSPQPSGELPRK | 21 | Q92619 | |
| TADEPPPKNGRAGAP | 126 | Q2Q1W2 | |
| PGSGVRVSPKSPPTD | 1356 | Q9BY89 | |
| RPGAGPPKAESGQEP | 121 | Q9UQF2 | |
| VTQRAGPAAPPPEKE | 286 | Q9NYG8 | |
| NGERPPGAKEAPPLT | 426 | Q8TD08 | |
| PPKDPRSNPRLNGGV | 536 | Q5FYB0 | |
| IGGKNEPEPEQPIPR | 271 | Q8IWQ3 | |
| VQGPPDPGRRTAPLK | 1326 | Q8ND23 | |
| PDENKRTPSPGPVES | 861 | Q5T0W9 | |
| DKEGVPQPSGPPARK | 6 | P07992 | |
| PQDGPGSRTTPDKAP | 611 | Q9NQC1 | |
| QPRAEAPSKGPDGTP | 406 | Q5XUX0 | |
| PHGAEEGTAVPPKRP | 471 | Q9H6A9 | |
| PGREAQPEAGAKKPP | 71 | Q96B70 | |
| PVRLPHEGSPSPGEK | 1281 | O15018 | |
| PKGRELDPAAPPEGQ | 76 | Q9Y4A8 | |
| EPSIRKPAGEGPQPR | 86 | Q6X4W1 | |
| PSGPESPVQGPRIKH | 856 | Q9UMN6 | |
| PERIPGGTDSPKRGP | 446 | Q96N21 | |
| PVSPAPSPTRGIGKQ | 141 | Q96E09 | |
| APSDQGKGKARPPEP | 741 | Q6NV74 | |
| CGKQGPATPAPEPSR | 26 | P29474 | |
| EGPNKLSPRIDGPPT | 771 | O94913 | |
| PVSQPRGPGQPTKSR | 271 | O43614 | |
| VPPVPRTAPVSKGEG | 156 | Q6PRD7 | |
| RSKPSSPGPGPEIKN | 836 | P32927 | |
| GRQSPAKPEEPGAPE | 46 | O15499 | |
| AKVRQPEGPESSPSP | 36 | A4D1S0 | |
| KPIPLPRFTEGGNPT | 306 | Q8WV28 | |
| KNPAPPEGKPSSGRD | 111 | Q96GS4 | |
| PKESPSRGPAPPQEN | 486 | Q9NYF0 | |
| GISTLERGQKPPPTP | 21 | Q9Y4F1 | |
| SFDTPVKGPPQGPRL | 1641 | Q8TD84 | |
| SPRDPKAPGQFGRPV | 431 | Q7Z7M9 | |
| PVEGPLSPSRGDFPK | 681 | O00512 | |
| LSPSRGDFPKGIPPQ | 686 | O00512 | |
| GTPGDPARPPASKAV | 331 | Q7Z7A3 | |
| PSPPGPEERKGQKRD | 1016 | Q6ZU35 | |
| PRAPGQAPPGKALVE | 821 | A8MPP1 | |
| PPQPEGAADKGDPRT | 201 | P31277 | |
| SEPKPEQAPRSPGSQ | 76 | P10075 | |
| PEPGRPGEESPAPKQ | 326 | Q8TBE0 | |
| IRGVPGTEPEKDPGP | 186 | Q6QNY0 | |
| EARGKGPGPQKPPTE | 2416 | O15021 | |
| QQEPTGEPSPKRPRG | 36 | P52926 | |
| VPPASGTHREKGPPT | 36 | Q5TBA9 | |
| GDPPLGDQKPPASLR | 1111 | O95180 | |
| PAPSGKSEVPERPNN | 721 | Q5FWE3 | |
| QGRAGAPVPEPPKEE | 26 | Q9Y2J2 | |
| DKRPLSGPDVGTPQP | 176 | O96013 | |
| RPGKPGEPEAPVLTH | 316 | Q96NZ1 | |
| SGPGAVVRPPKAPED | 51 | Q9GZR2 | |
| ELSPGPPKPAGREVE | 66 | Q8IZ73 | |
| GPASGPAQEKKEPPS | 46 | A6NKG5 | |
| GEKAPFTLRTPPGPA | 1886 | Q5T011 | |
| SEKVPPSGPGPAVRV | 996 | Q8N1F8 | |
| PAGRFPDQKPEVAPS | 306 | Q9Y2J0 | |
| PGTRPEDEAEGKPPQ | 26 | P31641 | |
| KPRVPVPTGAFDGPL | 1186 | Q07890 | |
| PPPGQTVRPGVKESL | 1821 | P35499 | |
| EPPPVTPQVGEGRKS | 436 | Q9UPR3 | |
| GDQPPATSVPAPRAK | 6786 | Q8WXH0 | |
| LCSPGPSQPGEKRPE | 36 | Q96ER9 | |
| GTKARPVPPPDNAAT | 311 | Q9H6K5 | |
| DRQAVPGRPGPFPSK | 421 | Q9Y520 | |
| PGRPGPFPSKQQVAD | 426 | Q9Y520 | |
| VEPKGDGIGPTRQPP | 616 | P48634 | |
| GRKPGPETGVPQSRP | 566 | Q68DV7 | |
| PEDSRPKPEQEAGPG | 671 | O43147 | |
| APPKGEKEGQRPTQP | 131 | Q9H0W8 | |
| QPPKDSPLGPCRGES | 946 | Q92835 | |
| PKTEQESITPGGRPP | 1061 | O60292 | |
| PGPTKAPSGRPNVAE | 221 | Q9ULL8 | |
| EPRPGEAKAEGAAPP | 6 | Q99801 | |
| PSGQTEREPKPGPSH | 91 | Q9NWF9 | |
| GTQGSPSKPKPEDPR | 281 | Q8TBJ4 | |
| TEGPTVVPRPGLKPA | 56 | O43597 | |
| AAPVKGQTGPERPSP | 6 | A7E2S9 | |
| KRPESVGGLEPPGPS | 601 | Q96RK0 | |
| PASPVAGSPKQPVRG | 176 | Q13057 | |
| GAGPEPPVLPIRSEK | 26 | Q9H2X0 | |
| PADPQSGEGVPPNRK | 16 | Q32M92 | |
| PNRLPEGSTVGPKPD | 26 | Q8N1V8 | |
| KAGREEEQPPPPAGL | 16 | A0A1B0GVM6 | |
| KAQGPRGDLGSPDPP | 161 | O00294 | |
| SSPEGNGSPEPKRPG | 76 | Q9UN79 | |
| PGATKIVPVEAGPPE | 211 | Q9P243 | |
| KPSTPIPPQEGEEVG | 1051 | Q9UDY2 | |
| EDPGETPKHQPGSPR | 31 | Q9Y548 | |
| RTKTAAQGPPPEGEP | 3336 | Q96T58 | |
| RPEGTTLRQGPPQKP | 2951 | Q15772 | |
| KTPSGPGRPQERNPT | 111 | Q8IWN7 | |
| VALGAQGPREKPAPP | 791 | Q96GP6 | |
| EPPAQAAPGPSKRDS | 471 | O94804 | |
| PTGSEPGDTRAKPPV | 26 | Q9C0C2 | |
| KEQPGPERPIPAGDG | 1776 | O95359 | |
| AGPASPEGPREKQLP | 1196 | Q86YV5 | |
| EGPGLQQKPRPEAEP | 116 | Q8WUA7 | |
| RPKPGAGVPDFLPSA | 751 | Q9UPT8 | |
| GAPPPEGRQSVELPK | 341 | Q4KMQ1 | |
| TPGRSGVTAEKAPPP | 451 | O60346 | |
| EPKPEEPPARGGLAS | 686 | Q9NS98 | |
| EPPARGGLASTPPKA | 691 | Q9NS98 | |
| QDVGSPDKARGPPVP | 556 | Q9Y3S1 | |
| EGRAEAPGQPLKPPE | 631 | Q9UEG4 | |
| PPEARVPGKAQPEVD | 401 | O75127 | |
| RLPPGSNGEVPKVPV | 271 | Q9ULD5 | |
| GTVPATPPEKPSEGR | 26 | Q14679 | |
| KSQGDPQPEAPPKGD | 576 | Q702N8 | |
| GSVPKPDAPVQAEPR | 241 | Q9UDV7 | |
| NQPPKGGPEPRSSGR | 26 | Q8NBV4 | |
| GTPAPPDGPKRFDQL | 256 | Q9H2S5 | |
| FLPSKPGARPQPEGA | 56 | O15069 |